» Articles » PMID: 39022015

Research Progress of Ganoderma Lucidum Polysaccharide in Prevention and Treatment of Atherosclerosis

Overview
Journal Heliyon
Specialty Social Sciences
Date 2024 Jul 18
PMID 39022015
Authors
Affiliations
Soon will be listed here.
Abstract

Atherosclerosis (AS) is a chronic inflammatory disease resulting from dysregulated lipid metabolism, constituting the pathophysiological foundation of cardiovascular and cerebrovascular diseases. AS has a high incidence rate and mortality rate worldwide. As such, traditional Chinese medicine (TCM) has been widely used recently due to its stable therapeutic effect and high safety. Ganoderma lucidum polysaccharides (GLP) are the main active ingredients of Ganoderma lucidum, a Chinese herbal medicine. Research has also shown that GLP has anti-inflammatory and antioxidant properties, regulates gut microbiota, improves blood glucose and lipid levels, and inhibits obesity. Most of the current research on GLP anti-AS is focused on animal models. Thus, its clinical application remains to be discovered. In this review, we combine relevant research results and start with the pathogenesis and risk factors of GLP on AS, proving that GLP can prevent and treat AS, providing a scientific basis and reference for the future prevention and treatment of AS with GLP.

Citing Articles

The Addition of Hot Water Extract of Juncao-Substrate Residue to Diets Enhances Growth Performance, Immune Function, and Intestinal Health in Broilers.

Gao Y, Liu X, Zhou Y, He J, Di B, Zheng X Animals (Basel). 2024; 14(20).

PMID: 39457856 PMC: 11503797. DOI: 10.3390/ani14202926.

References
1.
McCormack J, Westergaard N, Kristiansen M, Brand C, Lau J . Pharmacological approaches to inhibit endogenous glucose production as a means of anti-diabetic therapy. Curr Pharm Des. 2001; 7(14):1451-74. DOI: 10.2174/1381612013397393. View

2.
Murray P . Macrophage Polarization. Annu Rev Physiol. 2016; 79:541-566. DOI: 10.1146/annurev-physiol-022516-034339. View

3.
Devaki M, Nirupama R, Yajurvedi H . Chronic stress-induced oxidative damage and hyperlipidemia are accompanied by atherosclerotic development in rats. Stress. 2012; 16(2):233-43. DOI: 10.3109/10253890.2012.719052. View

4.
Bjorkegren J, Lusis A . Atherosclerosis: Recent developments. Cell. 2022; 185(10):1630-1645. PMC: 9119695. DOI: 10.1016/j.cell.2022.04.004. View

5.
Du Y, Li X, Su C, Xi M, Zhang X, Jiang Z . Butyrate protects against high-fat diet-induced atherosclerosis via up-regulating ABCA1 expression in apolipoprotein E-deficiency mice. Br J Pharmacol. 2019; 177(8):1754-1772. PMC: 7070171. DOI: 10.1111/bph.14933. View